Nonalcoholic Fatty Liver Disease: Changes in Gut Microbiota and Blood Lipids.

Keen YangJieying ZengHuaiyu WuHuiyu LiuZhimin DingWeiyu LiangLinghu WuZiwei LinWenhui HuangJinfeng Xu FaJin Dong

Published in: Journal of clinical and translational hepatology (2024)

, combined with glutamate pyruvic transaminase, aspartate aminotransferase, and white blood cell count distinguished NAFLD. We speculate that regulating the health of gut microbiota may release NAFLD, in addition to providing new targets for clinicians to treat NAFLD.

Keyphrases

healthcare
public health
single cell
mental health
cell therapy
health information
peripheral blood
mesenchymal stem cells
risk assessment
health promotion